全球慢病管理形势严峻。据华经产业研究院发布的《2025-2031年中国慢病管理行业市场深度分析及投 资前景展望报告》数据显示，2024年全球死于慢性病人数约4273万人。目前，慢性病已成为全球70岁以 下人群死亡的主要原因。 "AI+慢病管理"能碰撞出怎样的火花？ 今年9月，方舟健客携杏石大模型登上《Nature》头版头条，《Nature》聚焦中国人工智能浪潮之下慢病 管理的创新模式，着重介绍了方舟健客杏石大模型的技术底座及其研发背景。 澳大利亚悉尼科技大学专注于中国创新研究的科技政策学者MarinaZhang指出："方舟健客是中国在医疗 健康领域探索AI应用的先行者，其正凭借AI技术的独特优势，切入此前未被充分开发的市场。此外， 这一探索也具有更深层价值，那就是为破解全球慢病管理难题注入创新力量。" 近年来，方舟健客更将原有平台迭代升级，构建起更专业、更智能、更高效的"方舟健客AI+H2H智慧 医疗新生态"（以下简称"AI+H2H新生态"），以优势AI技术驱动医患服务的升级，为患者带来从医院到 家庭的无缝医疗服务体验。 当下，AI技术已在方舟健客的医疗服务中实现全面渗透。其自主研发的杏石大模型集成多模态能力 ...

医疗行业跨界洞察 本文来自微信公众号： 健闻咨询 ，作者：毛晓琼、李琳，原文标题：《问诊单量下降40%，基层医 生排不上班，线上问诊会是第一个被AI干掉的医疗赛道吗？》，题图来自：AI生成 做了近10年的线上问诊，舒浩没有想到，变化会来得如此之快。 舒浩是国内某头部三甲医院的一名内科高年资主治，从2016年开始接触线上问诊，几家主流的在线 问诊平台他都注册了个遍。从单量上来看，他在几个核心平台都算是靠前的，一个月平均能接500单 左右。 今年10月下旬，他所服务的某个主力平台发布了一款AI健康管家类产品。当时，这个偏行业侧的消 息并没有引起他的重视。直到11月过半，他发现自己在该平台上的线上问诊量缩水了40%左右。 以下文章来源于健闻咨询 ，作者健闻咨询 健闻咨询 . "其它平台的问诊量之前也有一些下降，大概在20%左右。"舒浩说。 在某互联网医疗公司任职的苏玉更早捕捉到了这种趋势，她所在的公司很早就围绕线上问诊做了独立 的业务布局，医生黏性强，在用户端的口碑也很好。 但从2024年下半年开始，她发现问诊平台的单量开始平稳下滑，"当时我们都不知道原因，后来接触 AI多了，大家才意识到，很多浅层的，和医疗健康相 ...

但从2024年下半年开始，她发现问诊平台的单量开始平稳下滑，"当时我们都不知道原因，后来接触AI 多了，大家才意识到，很多浅层的，和医疗健康相关的咨询已经开始被AI替代了。" "所有常规标准化的问诊，都会逐步被AI取代。"长期从事互联网医疗相关工作的资深人士徐晓向《健闻 咨询》表示，在他看来，这部分可被替代的问诊需求，在所有线上问诊场景里的占比接近80%。 做了近10年的线上问诊，舒浩没有想到，变化会来得如此之快。 舒浩是国内某头部三甲医院的一名内科高年资主治，从2016年开始接触线上问诊，几家主流的在线问诊 平台他都注册了个遍。从单量上来看，他在几个核心平台都算是靠前的，一个月平均能接500单左右。 今年10月下旬，他所服务的某个主力平台发布了一款AI健康管家类产品。当时，这个偏行业侧的消息 并没有引起他的重视。直到11月过半，他发现自己在该平台上的线上问诊量缩水了40%左右。 "其它平台的问诊量之前也有一些下降，大概在20%左右。"舒浩说。 在某互联网医疗公司任职的苏玉更早捕捉到了这种趋势，她所在的公司很早就围绕线上问诊做了独立的 业务布局，医生黏性强，在用户端的口碑也很好。 巧合的是，最近互联网医疗行业 ...

Core Insights - The core theme of the conference was "Collaborative Win-Win: Smartly Leading the Future," focusing on enhancing chronic disease management through artificial intelligence [1][2] - The strategic partnership between Fangzhou Jianke and Suzhou Wangshan Wangshui Biopharmaceutical Co., Ltd. aims to explore innovative approaches in the health industry empowered by AI [1][6] Industry Trends - The National Health Commission issued guidelines promoting the application of AI in healthcare, outlining core goals and pathways for the next five years [2] - The aging population and the increasing prevalence of chronic diseases in younger demographics highlight the critical role of AI technology in healthcare [2] Company Developments - Fangzhou Jianke's CEO, Dr. Xie Fangmin, emphasized the importance of addressing real problems and driving genuine change in chronic disease management through AI [2][4] - The user engagement with the "AI Health Steward" platform has significantly increased, with user numbers in October being 2.4 times that of September and GMV rising by 50% [4] Strategic Collaborations - The partnership with Wangshan Wangshui is designed to integrate technological empowerment with product pipeline advantages, aiming for a comprehensive upgrade from drug supply to health services [6][8] - Both companies plan to create replicable and scalable AI-driven solutions for chronic disease management, enhancing the quality of development in the health industry [5][6]

Core Insights - The core theme of the conference was "Collaborative Win-Win: Smartly Leading the Future," focusing on enhancing chronic disease management through artificial intelligence [1][2] - A strategic partnership was formed between Fangzhou Jianke and Suzhou Wangshan Wangshui Biopharmaceutical Co., Ltd., aimed at integrating core industry resources with digital technology capabilities [1][5] Industry Trends - The Chinese government has emphasized the importance of "AI+" in various sectors, particularly in healthcare, as outlined in the recent policy documents [2] - The aging population and the increasing prevalence of chronic diseases in China present significant opportunities for AI applications in healthcare [2] Company Developments - Fangzhou Jianke's CEO, Xie Fangmin, highlighted the company's commitment to solving real problems in chronic disease management through AI technology [2][4] - The company reported a 2.4 times increase in users experiencing AI features in October compared to September, with a 50% increase in Gross Merchandise Volume (GMV) [4] Strategic Collaboration - The partnership between Fangzhou Jianke and Wangshan Wangshui aims to break down industry barriers and enhance the entire health service chain from drug supply to health services [5][6] - Both companies plan to leverage their respective strengths to create a customer-centric health service system, providing comprehensive health management solutions [5][6] Future Outlook - The collaboration is expected to facilitate a more efficient connection between biopharmaceutical research and health services, ensuring that research outcomes meet user needs [6] - Fangzhou Jianke aims to continue its focus on chronic disease management and enhance its technological foundation to drive digital upgrades in health services [6]

Core Insights - The core theme of the conference was "Collaborative Win-Win: Smartly Leading the Future," focusing on enhancing chronic disease management through artificial intelligence [1][2] Group 1: Strategic Partnerships - Ark Health and Suzhou Wangshan Wangshui Biopharmaceutical Co., Ltd. announced a strategic cooperation aimed at integrating core industry resources with digital technology capabilities [1][5] - The partnership is designed to break down industry barriers and achieve a full-chain upgrade from drug supply to health services [5][6] Group 2: AI and Chronic Disease Management - The Chinese government has emphasized the importance of "AI + healthcare," providing a clear direction for the industry's development over the next five years [2][4] - Ark Health's CEO highlighted the critical role of AI in addressing the challenges posed by an aging population and the increasing prevalence of chronic diseases [2][4] Group 3: Technological Advancements - The application of AI technology has led to significant user engagement, with a 2.4 times increase in users experiencing AI features in October compared to September, and a 50% increase in GMV [4] - The company aims to create replicable and scalable AI-driven solutions for chronic disease management, enhancing the quality of health services [4][6] Group 4: Future Outlook - The collaboration is expected to enhance the alignment between biopharmaceutical research and health service delivery, ensuring that research outcomes meet user needs more effectively [6] - Ark Health plans to continue deepening its focus on chronic disease management and strengthening its technological foundation to drive the digital transformation of health services [6]

Core Insights - The article discusses the successful convening of the Ark Health (方舟健客) Double 12 Core Partner Summit, focusing on the theme "Collaborative Win-Win, Intelligent Future," which gathered key players in the internet healthcare industry to explore the enhancement of chronic disease management through artificial intelligence [1][2] - A strategic partnership was announced between Ark Health and Suzhou Wangshan Wangshui Biopharmaceutical Co., Ltd. (旺山旺水), aimed at integrating core industry resources with digital technology capabilities to drive innovation in the health industry [1][6] Industry Trends - The Chinese government has emphasized the importance of "AI+" initiatives across various sectors, including healthcare, as part of its strategic direction for the next five years [1][2] - The aging population and the increasing prevalence of chronic diseases among younger individuals highlight the critical role AI technology can play in healthcare [2] Company Developments - Ark Health's CEO, Dr. Xie Fangmin, highlighted the company's commitment to addressing real problems and delivering tangible changes in chronic disease management through AI applications [2][5] - The company reported a significant increase in user engagement with its AI features, with a 2.4 times increase in users experiencing AI functionalities and a 50% rise in Gross Merchandise Volume (GMV) in October compared to September [4] Strategic Collaboration - The partnership between Ark Health and Wangshan Wangshui is designed to break down industry barriers and integrate technological empowerment with product pipeline advantages, facilitating a comprehensive upgrade from drug supply to health services [5][6] - Both companies aim to create a customer-centric health service system, providing tailored, efficient, and professional health management solutions throughout the entire lifecycle [6][8] Future Outlook - The collaboration is expected to enhance the connection between biopharmaceutical research and health services, ensuring that research outcomes align more closely with user needs [8] - Ark Health plans to continue its focus on chronic disease management, strengthening its technological foundation and enhancing application scenarios to promote digital transformation in health services [9]

Core Insights - The annual list of top 100 enterprises in Zhejiang serves as an important indicator of the development of local companies, with total revenue exceeding 10 trillion yuan for three consecutive years, and 33 companies reporting revenues over 100 billion yuan, an increase of 2 from the previous year [1] - The growth of Zhejiang enterprises is driven by continuous investment in technological innovation, with 89 companies holding a total of 178,180 patents, marking an increase of 17,811 patents (11.11%) from the previous year [1] Group 1: Revenue and Rankings - Alibaba Group leads the list with a revenue of 996.35 billion yuan, followed by Rongsheng Holding Group at 658.60 billion yuan and Geely Holding Group at 574.83 billion yuan [12] - The top 10 companies by revenue include notable names such as Hikvision, NetEase, and Ant Group, with revenues ranging from approximately 924.96 million yuan to 996.35 billion yuan [12][13] Group 2: R&D Investment - Geely Holding Group ranks first in R&D investment with 266.65 billion yuan, a 16.3% increase from the previous year, and has committed over 100 billion yuan for R&D from 2021 to 2025 [9][10] - Ant Group follows with an R&D investment of 234.59 billion yuan, a 10.7% increase, and leads in patent holdings with 23,550 patents [7][10] - NetEase ranks third with an R&D investment of 175.25 billion yuan, reflecting a 6.3% year-on-year growth, and has focused on AI technology to enhance user experience in various sectors [5][10] - Hikvision, the largest security company globally, invested 118.64 billion yuan in R&D, maintaining a research expense ratio exceeding 10% for five consecutive years [3][10] Group 3: Technological Innovation - The manufacturing sector dominates patent holdings, with 65 companies owning 137,551 patents, while the service sector holds 37,859 patents [1] - Companies like Ant Group and NetEase are heavily investing in AI technologies, with Ant Group launching three AI assistants that have served over 130 million users [7] - Geely has been recognized for its innovation in hybrid power control technology, leading the industry in several patent metrics [9]

Core Insights - The 2025 World Internet Conference in Wuzhen introduced a new forum focused on the integration of digital intelligence technology in healthcare, emphasizing innovative pathways for medical applications [1] Group 1: AI in Healthcare - The forum highlighted the fusion of medical artificial intelligence with brain science and the application of AI in healthcare, discussing how big data and AI can transition from laboratories to clinical settings [1] - Experts discussed the importance of "humanizing technology" and shared insights on the role of AI in enhancing chronic disease management and treatment [3][5] - AI is seen as a crucial tool for improving chronic disease screening and management through monitoring and wearable devices [3] Group 2: AI Health Assistant - An AI health assistant showcased at the conference can interpret health reports, identify skin conditions, and provide AI consultations, addressing the pressure on medical resources and enhancing daily health management for the public [6] - This AI application can analyze uploaded health report images or PDFs, quickly parse data, and suggest health risks and treatment recommendations [6][8] - The AI health application also allows for real-time monitoring of elderly patients' health by linking their health records with their children's accounts, facilitating a one-stop service for consultation and appointment booking [10]

Core Insights - The article highlights the increasing elderly population in China, projected to reach 310 million by the end of 2024, emphasizing the importance of elder care services as a significant social issue [1] - Technological advancements, particularly AI, are playing a crucial role in enhancing the quality of life for the elderly, enabling them to engage in learning and health recovery [2][4] Group 1: Elderly Population and Care Services - By the end of 2024, the elderly population (aged 60 and above) in China is expected to reach 310 million [1] - The government has implemented multiple policies to create a more elder-friendly society, ensuring better care and enjoyment for the elderly [1] Group 2: Technological Integration in Elderly Care - AI technology is being utilized to improve elderly education and health, allowing seniors to engage in activities like recitation and recovery training [2][4] - As of the end of 2024, there are 68,000 grassroots elderly education learning points established across urban and rural communities, facilitated by AI [5] Group 3: Smart Elderly Care Platforms - During the 14th Five-Year Plan period, China is enhancing its three-tier elderly care service system through smart platforms that integrate institutional, community, and home care services [8] - In Dalian, a smart elderly care platform connects over 400 nursing homes and home care service providers, allowing seniors to access various services via mobile apps [8][10] Group 4: Personalized Services and Support - The smart elderly care system in Changzhou utilizes big data and cloud technology to match elderly needs with available services, creating a more intelligent care ecosystem [11] - The system includes features like emergency calls and remote monitoring, ensuring a 24-hour responsive "smart housekeeper" service for the elderly [11] - It also connects seniors with local dining options and personalized services, addressing individual needs such as medical appointments [13][14]